compound introduction
描述及优势 •提供1015种片段小分子集合，可用于基于片段的新药发现(FBDD) •FBDD已经成为传统的高通量筛选(HTS)药物的替代方法 •这些低分子量的片段非常适合筛选具有良好药物特性的临床候选药物，同时通过FBDD筛选出来的越来越多的化合物正在进入临床 •FBDD可以节省研究成本，并且可以更容易地筛选出高性能药物 详细信息 配制 1015个化合物预溶于10mM DMSO 容器 带有螺旋盖和二维码的96孔储存管 储存条件 1年 -20°C溶于DMSO 2年 -80°C溶于DMSO • A unique collection of 1015 Fragment compounds for Fragment-Based Drug Discovery (FBDD) • FBDD has emerged as an alternative approach for high-throughput screening (HTS) in discovering drug • These fragments with low molecular weight are extremely suitable for screening clinical candidates with good drug-like properties,and more and more compounds discovered by FBDD are entering the clinic • FBDD can save research cost and make it easier to screen high-performance drugs
